- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- ROUNDTABLE: Pharmacy’s future in sync with technology
- FDA advisory panel to consider OTC status of NSAIDs
- Perrigo recalls APAP infant suspension liquid due to the possibility of missing dose markings on the dosing syringe
PHILADELPHIA — The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.
Lannett announced the approval of butalbital, acetaminophen and caffeine tablets in the 50-mg/325-mg/40-mg strength. the drug is a generic version of Watson Pharmaceuticals' Fioricet.
Branded and generic versions of the drug had sales of $30 million during the 12-month period ended in July, including $15 million for branded Fioricet. Lannett plans to start shipping its version next month, the company said.